Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 26,706 shares at $15.51 ($414K) on 2018-03-05, disclosed to the SEC on 2018-03-07.
Open-market sale of $414k CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.51 | 13,353 | $207K | 50.0% |
| 2 | $15.51 | 13,353 | $207K | 50.0% |
| Total | $15.51 avg | 26,706 | $414K | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |